Doctors at the University of Washington and the Seattle Children’s Hospital describe how a 13-month-old girl was eventually identified as a child abuse victim, after initially being diagnosed with corneal abrasion and a mild infection. The case study …
Month: April 2012
Horizon scanning: Iluvien® (fluocinolone acetonide intravitreal implant) approved in Austria for chronic diabetic macular oedema
Source: Globe Newswire (via BioSpace)
Area: News
The Austrian Agency for Health and Food Safety has approved Iluvien® (fluocinolone acetonide intravitreal implant) for the treatment of vision impairment associated with chronic diabetic macular oedema…
Social Media RoundTable and Article on Doctors’ Transparency
We just got back from Chicago where we discussed what we’ve learned on social media and medicine. I also had an article published at KevinMD.com
American Society of Cataract and Refractive Surgery (ASCRS) 2012 Symposium on Cataract, IOL and Refractive Surgery
Read clinically focused news coverage of key developments from the meeting. Medscape Ophthalmology
New Treatment For Degenerative Vision Disorder Leber Hereditary Optic Neuropathy
A research team, led by John Guy, M.D., professor of ophthalmology at Bascom Palmer Eye Institute of the University of Miami Miller School of Medicine, has pioneered a novel technological treatment for Leber Hereditary Optic Neuropathy (LHON), an inher…
Iluvien Update 6: First European Marketing Approval Obtained
While U.S. marketing approval appears to be out of reach for Alimera and pSivida for Iluvien for the sustained release treatment of diabetic macular edema, the first of six expected approvals for Europe has been obtained. The companies announced that t…
Medicare Trustees Forecast Bleak Future for Program
The trustees of the federal program say the outlook could go from bad to worse depending on some fiscal wildcards, which include the notorious sustainable growth rate formula. Medscape Medical News
NHS faces legal challenge from Novartis over use of intravitreal bevacizumab (AvastinT) for wet AMD
Source: BBC Health
Area: News
The BBC has reported that Novartis is challenging the NHS on the use of intravitreal bevacizumab (AvastinT) instead of the NICE-recommended ranibizumab (LucentisT) for the treatment of wet age-related macular degeneratio…
Acute Painless Monocular Vision Loss
A 55-year-old woman with a remote history of facial palsy wakes up one morning with blurred vision, glare, and decreased color perception in one eye. What is your diagnosis? Medscape Ophthalmology
One Strategy for Growth: Buy ’em Up
The common strategy for growth: Build and keep your fair share of the market by providing good service. But could buying practices in your area be a better option? Medscape Business of Medicine
Diet, Exercise, and Age-Related Macular Degeneration
Here are some concrete ways that patients can preserve their long-term vision. Medscape Ophthalmology
Computational adaptive optics for real-time in-vivo applications
Real-time, 3-D microscopic tissue imaging could be a revolution for medical fields such as cancer diagnosis, minimally invasive surgery and ophthalmology. University of Illinois researchers have developed a technique to computationally correct for aber…
R-Tech Ueno completes RK-023 phase I study on hypotrichosis of the eyelashes
R-Tech Ueno is pleased to announce the completion of a phase I clinical study of RK-023, a new compound that is being developed for the treatment of hypotrichosis of the eyelashes.
Novel technological treatment for Leber Hereditary Optic Neuropathy
A research team, led by John Guy, M.D., professor of ophthalmology at Bascom Palmer Eye Institute of the University of Miami Miller School of Medicine, has pioneered a novel technological treatment for Leber Hereditary Optic Neuropathy (LHON), an inher…
Alimera eye drug inches closer to launch with Austria approval
Novartis challenges UK Avastin use in eye disease
ZURICH/LONDON (Reuters) – Swiss drugmaker Novartis is challenging the use of a cheap alternative to
its eye drug Lucentis in parts of Britain, sparking a row over cost versus safety in treating a common cause of
blindness.
Big Regional Differences in Glaucoma Diagnosis Found
A new analysis of Medicare records finds dramatic differences across the United States in rates of new glaucoma diagnoses. Reuters Health Information
Cosmetic contact lens on the rise among Malaysians
Malaysia’s beauty contact lens market is fast catching up with developed countries in the region such as Singapore, Taiwan and South Korea, which are all exhibiting similar upward trending in the sales of these beauty accessories. GfK retail tracking…
Congenital Glaucoma: Would You Recognize It?
Primary care providers must promptly recognize this rare condition and refer promptly in order to preserve vision in affected infants. CHOP Expert Commentary
Congenital Glaucoma: Would You Recognize It?
iTunes conversion to RSS provided by Feed Flipper: [Web] – [Facebook] – [Donate!]
Primary care providers must promptly recognize this rare condition and refer promptly in order to preserve vision in affected infants.